{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26263160", "DateCompleted": {"Year": "2016", "Month": "05", "Day": "10"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "08", "Day": "11"}], "ELocationID": ["e0135721", "10.1371/journal.pone.0135721"], "Language": ["eng"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "8", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Novel Approach to Identify Potential Bioactive Plant Metabolites: Pharmacological and Metabolomics Analyses of Ethanol and Hot Water Extracts of Several Canadian Medicinal Plants of the Cree of Eeyou Istchee.", "Pagination": {"StartPage": "e0135721", "MedlinePgn": "e0135721"}, "Abstract": {"AbstractText": ["We evaluated and compared the antidiabetic potential and molecular mechanisms of 17 Cree plants' ethanol extracts (EE) and hot water extracts (HWE) on glucose homeostasis in vitro and used metabolomics to seek links with the content of specific phytochemicals. Several EE of medical plants stimulated muscle glucose uptake and inhibited hepatic G6Pase activity. Some HWE partially or completely lost these antidiabetic activities in comparison to EE. Only R. groenlandicum retained similar potential between EE and HWE in both assays. In C2C12 muscle cells, EE of R. groenlandicum, A. incana and S. purpurea stimulated glucose uptake by activating AMP-activated protein kinase (AMPK) pathway and increasing glucose transporter type 4 (GLUT4) expression. In comparison to EE, HWE of R. groenlandicum exhibited similar activities; HWE of A. incana completely lost its effect on all parameters; interestingly, HWE of S. purpurea activated insulin pathway instead of AMPK pathway to increase glucose uptake. In the liver, for a subset of 5 plants, HWE and EE activated AMPK pathway whereas the EE and HWE of S. purpurea and K. angustifolia also activated insulin pathways. Quercetin-3-O-galactoside and quercetin 3-O-\u03b1-L-arabinopyranoside, were successfully identified by discriminant analysis as biomarkers of HWE plant extracts that stimulate glucose uptake in vitro. More importantly, the latter compound was not identified by previous bioassay-guided fractionation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Health Products and Metabolic Disease Laboratory and Montreal Diabetes Research Center, Department of pharmacology, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada; Institute of Nutraceuticals and Functional Foods, Universit\u00e9 Laval, Quebec, Quebec, Canada."}], "LastName": "Shang", "ForeName": "Nan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada; Center for Advanced Research in Environmental Genomics, University of Ottawa, Ottawa, Ontario, Canada."}], "LastName": "Saleem", "ForeName": "Ammar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Health Products and Metabolic Disease Laboratory and Montreal Diabetes Research Center, Department of pharmacology, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada."}], "LastName": "Musallam", "ForeName": "Lina", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada; Center for Advanced Research in Environmental Genomics, University of Ottawa, Ottawa, Ontario, Canada."}], "LastName": "Walshe-Roussel", "ForeName": "Brendan", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Office for Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, Ontario, Canada."}], "LastName": "Badawi", "ForeName": "Alaa", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada; Jardin botanique de Montr\u00e9al, Institut de recherche en biologie v\u00e9g\u00e9tale, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada."}], "LastName": "Cuerrier", "ForeName": "Alain", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada; Center for Advanced Research in Environmental Genomics, University of Ottawa, Ottawa, Ontario, Canada."}], "LastName": "Arnason", "ForeName": "John T", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Health Products and Metabolic Disease Laboratory and Montreal Diabetes Research Center, Department of pharmacology, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal, Quebec, Canada; Institute of Nutraceuticals and Functional Foods, Universit\u00e9 Laval, Quebec, Quebec, Canada."}], "LastName": "Haddad", "ForeName": "Pierre S", "Initials": "PS"}], "GrantList": [{"GrantID": "CTP-79855", "Agency": "Canadian Institutes of Health Research", "Country": "Canada"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glucose Transporter Type 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.11.31", "NameOfSubstance": "AMP-Activated Protein Kinases"}, {"RegistryNumber": "EC 3.1.3.9", "NameOfSubstance": "Glucose-6-Phosphatase"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "AMP-Activated Protein Kinases"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Canada"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose Transporter Type 4"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glucose-6-Phosphatase"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Insulin"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "Metabolome"}, {"QualifierName": ["methods"], "DescriptorName": "Metabolomics"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Muscle Fibers, Skeletal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO, Diabetes Fact sheet N\u00b0312. 2013"}, {"Citation": "Leduc C, Coonishish J, Haddad P, Cuerrier A. Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: A novel approach in quantitative ethnobotany. J. Ethnobot. 2006; 105: 55\u201363.", "ArticleIdList": ["16297584"]}, {"Citation": "Kuzmina E, Dannenbaum D, Torrie J, Cree Diabetes Information System (CDIS) (2009) Annual Report, in Public Health Report Series 3 on Diabetes, P.H. Department, Editor. 2010. Cree Board of Health and Social Services of James Bay Chisasibi;"}, {"Citation": "Haddad PS, Musallam L, Martineau LC, Harris C, Lavoie L, Arnason JT, et al. Comprehensive evidence-based assessment and prioritization of potential antidiabetic medicinal plants: a case study from canadian eastern james bay cree traditional medicine. Evid Based Complement Alternat Med. 2012; 2012:893426 10.1155/2012/893426", "ArticleIdList": ["10.1155/2012/893426", "PMC3247006", "22235232"]}, {"Citation": "Spoor DC, Martineau LC, Leduc C, Benhaddou-Andaloussi A, Meddah B, Harris C, et al. Selected plant species from the Cree pharmacopoeia of northern Quebec possess antidiabetic potential. Can J Physiol Pharmacol. 2006; 84: 847\u2013858.", "ArticleIdList": ["17111029"]}, {"Citation": "Harbilas D, Martineau LC, Harris CS, Adeyiwola-Spoor DC, Saleem A, Lambert J, et al. Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II. Can J Physiol Pharmacol. 2009; 87: 479\u201392. 10.1139/y09-029", "ArticleIdList": ["10.1139/y09-029", "19526043"]}, {"Citation": "Nachar A, Vallerand D, Musallam L, Lavoie L, Badawi A, Arnason J, et al. The action of antidiabetic plants of the canadian james bay cree traditional pharmacopeia on key enzymes of hepatic glucose homeostasis. Evid Based Complement Alternat Med. 2013; 2013:189819 10.1155/2013/189819", "ArticleIdList": ["10.1155/2013/189819", "PMC3707264", "23864882"]}, {"Citation": "Ferrannini E, Simonson DC, Katz LD, Reichard G Jr, Bevilacqua S, Barrett EJ, et al. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism. 2004; 37: 79\u201385.", "ArticleIdList": ["3275860"]}, {"Citation": "Boustead JN, Martin CC, Oeser JK, Svitek CA, Hunter SI, Hutton JC, et al. Identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J Mol Endocrinol. 2004; 32: 33\u201353.", "ArticleIdList": ["14765991"]}, {"Citation": "Consoli A. Role of liver in pathophysiology of NIDDM. Diabetes Care. 1992; 15: 430\u201341.", "ArticleIdList": ["1559410"]}, {"Citation": "Muhammad A, Guerrero-Analco JA, Martineau LC, Musallam L, Madiraju P, Nachar A, et al. Antidiabetic Compounds from Sarracenia purpurea Used Traditionally by the Eeyou Istchee Cree First Nation. J Nat Prod. 2012; 75: 1284\u20131288. 10.1021/np3001317", "ArticleIdList": ["10.1021/np3001317", "22738356"]}, {"Citation": "Peyron-Caso E, Fluteau-Nadler S, Kabir M, Guerre-Millo M, Quignard-Boulang\u00e9 A, Slama G, et al. Regulation of glucose transport and transporter 4 (GLUT-4) in muscle and adipocytes of sucrose-fed rats: effects of N-3 poly- and monounsaturated fatty acids. Horm Metab Res. 2012; 34: 360\u2013366", "ArticleIdList": ["12189582"]}, {"Citation": "Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest. 1991; 87: 1072\u20131081.", "ArticleIdList": ["PMC329903", "1999488"]}, {"Citation": "Niu W, Bilan PJ, Ishikura S, Schertzer JD, Contreras-Ferrat A, Fu Z, et al. Contraction-related stimuli regulate GLUT4 traffic in C2C12-GLUT4 myc skeletal muscle cells. Am J Physiol Endocrinol Metab. 2010; 298: E1058\u201371. 10.1152/ajpendo.00773.2009", "ArticleIdList": ["10.1152/ajpendo.00773.2009", "20159855"]}, {"Citation": "Takazawa K, Noguchi T, Hosooka T, Yoshioka T, Tobimatsu K, Kasuga, M. Insulin-induced GLUT4 movements in C2C12 myoblasts: evidence against a role of conventional kinesin motor proteins. Kobe J Med Sci. 2008; 54: E14\u201322.", "ArticleIdList": ["18772605"]}, {"Citation": "Eid HM, Martineau LC, Saleem A, Muhammad A, Vallerand D, Benhaddou-Andaloussi A, et al. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol Nutr Food Res. 2010; 54: 991\u20131003. 10.1002/mnfr.200900218", "ArticleIdList": ["10.1002/mnfr.200900218", "20087853"]}, {"Citation": "Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002; 51: 2074\u20132081.", "ArticleIdList": ["12086935"]}, {"Citation": "Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care. 1990; 13: 696\u2013704.", "ArticleIdList": ["2162756"]}, {"Citation": "Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 2008; 57: 306\u201314.", "ArticleIdList": ["17909097"]}, {"Citation": "Zhang M, Lv X, Li J, Meng Z, Wang Q, Chang W, et al. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis. Mol. Cell Endocrinol. 2012; 363: 122\u2013130. 10.1016/j.mce.2012.08.006", "ArticleIdList": ["10.1016/j.mce.2012.08.006", "PMC3795615", "22922125"]}, {"Citation": "Yuan HD, Kim do Y, Quan HY, Kim SJ, Jung MS, Chung SH. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3beta via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells. Chem Biol Interact. 2012; 195: 35\u201342. 10.1016/j.cbi.2011.10.006", "ArticleIdList": ["10.1016/j.cbi.2011.10.006", "22062806"]}, {"Citation": "Moerman DE. Native American Ethnobotany, Portland: USA Timber Press; 2000."}, {"Citation": "Dufour D, Pichette A, Mshvildadze V, Bradette-H\u00e9bert ME, Lavoie S, Longtin A, et al. Antioxidant, anti-inflammatory and anticancer activities of methanolic extracts from Ledum groenlandicum Retzius. J Ethnopharmacol. 2007; 111: 22\u201328", "ArticleIdList": ["17156957"]}, {"Citation": "Chandler RF, Freeman L, Hooper SN. Herbal remedies of the Maritime Indians. J Ethnopharmacol. 1979;1: 49\u201368.", "ArticleIdList": ["544949"]}, {"Citation": "Gunther E. Ethnobotany of Western Washington. Seattle, USA: University of Washington Press; 1973."}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "3", "Day": "30"}, {"Year": "2015", "Month": "7", "Day": "25"}, {"Year": "2015", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["26263160", "PMC4532419", "10.1371/journal.pone.0135721", "PONE-D-15-13280"]}}], "PubmedBookArticle": []}